News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioReliance Corporation Announces IMP Manufacturing Agreement with Provecs Medical GmbH


11/18/2008 10:56:07 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance Corporation announced today that it has concluded an agreement with Provecs Medical GmbH, a company based in Hamburg, Germany, for production of investigational quantities of Immunalon®, a novel therapeutic agent based upon an adenovirus vector that stimulates an immunological response against tumor cells.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES